COVID-19 (Coronavirus Disease 2019)
13
2
4
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir
Physiological Finding in Management of COVID 19 Patients
A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
A Study to Learn About How Well Yearly Updates to the COVID-19 Vaccine Work to Protect People From COVID-19 and How Much Money People Spend on Healthcare for COVID-19
Clinical Study of Tanshinone Capsules Against COVID-19
Nebulised Dornase Alfa for Treatment of COVID-19 (Coronavirus Disease 2019)
Understanding COVID-19 Vaccine Immunity in Tissue and Blood
Thrombohemorrhagic Complications of COVID-19
University Hospital of Ioannina COVID-19 (Coronavirus Disease 2019) Registry
The Safety, Tolerability and Pharmacokinetics Study of RAY1216 in Healthy Adult Participants
Levels of Physical Activity After SARS-CoV-2 Infection in Pre-illness Vaccinated and Unvaccinated Greek Adults.
Convolutional Neural Network Model to Detect Coronavirus Disease 2019 (COVID-19) Pneumonia in Chest Radiographs